These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38617536)

  • 61. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PTEN-deficient tumors depend on AKT2 for maintenance and survival.
    Chin YR; Yuan X; Balk SP; Toker A
    Cancer Discov; 2014 Aug; 4(8):942-55. PubMed ID: 24838891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
    Kim J; Eltoum IE; Roh M; Wang J; Abdulkadir SA
    PLoS Genet; 2009 Jul; 5(7):e1000542. PubMed ID: 19578399
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM.
    McCabe N; Hanna C; Walker SM; Gonda D; Li J; Wikstrom K; Savage KI; Butterworth KT; Chen C; Harkin DP; Prise KM; Kennedy RD
    Cancer Res; 2015 Jun; 75(11):2159-65. PubMed ID: 25870146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.
    Lin PY; Fosmire SP; Park SH; Park JY; Baksh S; Modiano JF; Weiss RH
    Mol Cancer; 2007 Feb; 6():16. PubMed ID: 17300726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
    Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
    Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.
    Luo H; Yang Y; Duan J; Wu P; Jiang Q; Xu C
    Cell Death Dis; 2013 Feb; 4(2):e481. PubMed ID: 23392169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
    Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.
    Qi H; Lou M; Chen Y; Liu X; Chen N; Shan J; Ling Z; Shen J; Zhu L; Yen Y; Zheng S; Shao J
    Tumour Biol; 2015 Jun; 36(6):4833-42. PubMed ID: 25638032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of BET bromodomain targets genetically diverse glioblastoma.
    Cheng Z; Gong Y; Ma Y; Lu K; Lu X; Pierce LA; Thompson RC; Muller S; Knapp S; Wang J
    Clin Cancer Res; 2013 Apr; 19(7):1748-59. PubMed ID: 23403638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
    Zhong D; Gu C; Shi L; Xun T; Li X; Liu S; Yu L
    J Cell Biochem; 2014 Sep; 115(9):1624-35. PubMed ID: 24788582
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.
    Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
    Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
    Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
    Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S
    EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation.
    Sinn B; Tallen G; Schroeder G; Grassl B; Schulze J; Budach V; Tinhofer I
    Mol Cancer Ther; 2010 Feb; 9(2):480-8. PubMed ID: 20103602
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13- acetate-induced apoptotic cells.
    Lai JM; Wu S; Huang DY; Chang ZF
    Mol Cell Biol; 2002 Nov; 22(21):7581-92. PubMed ID: 12370305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.
    Lombardo Y; Scopelliti A; Cammareri P; Todaro M; Iovino F; Ricci-Vitiani L; Gulotta G; Dieli F; de Maria R; Stassi G
    Gastroenterology; 2011 Jan; 140(1):297-309. PubMed ID: 20951698
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer.
    Song M; Chen D; Lu B; Wang C; Zhang J; Huang L; Wang X; Timmons CL; Hu J; Liu B; Wu X; Wang L; Wang J; Liu H
    PLoS One; 2013; 8(6):e65821. PubMed ID: 23785454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.